165 results
Page 7 of 9
6-K
EX-99
rmwqo5pq6f4cmi3
24 Oct 12
Current report (foreign)
12:00am
6-K
EX-99
uyhmcz6zy
16 Oct 12
BioLineRx Announces Successful Completion of Pre-Clinical
12:00am
424B3
wbi fpdzilyy
15 Oct 12
Prospectus supplement
12:00am
6-K
EX-99
8jxedzq9
9 Oct 12
BioLineRx Announces New Analysis of EAGLE Phase IIb
12:00am
F-1
qg7cqpv
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99.1
oauhgv
27 Sep 12
Current report (foreign)
12:00am
6-K
EX-99
a1w 432khvxni9lb9e
24 Sep 12
BioLineRx Receives Notice of Allowance from USPTO
12:00am
6-K
EX-99
o385 xw9g
10 Sep 12
BioLineRx Announces Pre-clinical Results Demonstrating
12:00am
6-K
EX-99.1
bdej2 xgieqwsip4v
4 Sep 12
Current report (foreign)
12:00am
6-K
EX-99
qsmjmbxt8dj7njhg5sa
15 Aug 12
BioLineRx Reports Second Quarter 2012 Results
12:00am
F-3/A
EX-4.2
e2cwpxd3uabz
13 Aug 12
Shelf registration (foreign) (amended)
12:00am
F-3
q8mhhzjs4se
1 Aug 12
Shelf registration (foreign)
12:00am
6-K
EX-99
wz9vchd4
9 Jul 12
BioLineRx Receives Notice of Intention to Grant
12:00am
6-K
EX-99
pqu 7uxuck
5 Jun 12
BioLineRx Announces Receipt of Two Notices of
12:00am
6-K
EX-99
pxy fqhn8sba
25 Apr 12
BioLineRx Announces Extension of Patent
12:00am
424B3
6jwnag ulsxi
28 Mar 12
Prospectus supplement
12:00am
6-K
EX-99
iuaww3yl95bdw1l0mzid
22 Mar 12
BioLineRx Reports Fourth Quarter and Calendar 2011 Results
12:00am
20-F
k1sgy
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-99
88y4o8d0gk q35viwxl
7 Mar 12
BioLineRx Announces Grant of European Patent Covering
12:00am
6-K
EX-99
x9eqd9y9 aivsiu
5 Mar 12
BioLineRx Receives Approval for Commencing
12:00am